INS and type 2 diabetes mellitus: A study used magnetic resonance imaging to evaluate the liver fat content, volume of visceral adipose tissue, and abdominal subcutaneous adipose tissue in 296 individuals with T2DM treated with tirzepatide or insulin degludec participating in the SURPASS-3 study.